Advancing PFAS biomonitoring: What we measure and why it matters
As the global conversation around per‑ and polyfluoroalkyl substances (PFAS) moves beyond environmental detection, a new priority has emerged: accurately characterizing human exposure and biological impact. This requires not only understanding toxicological pathways, but also refining how we measure PFAS, which biomarkers matter most, and how analytical workflows shape health‑risk interpretation.
Join our expert panel, including advisors to the Department for Environment, Food and Rural Affairs (DEFRA) and the World Health Organization (WHO), as we bridge cutting‑edge analytical science with real‑world clinical and regulatory decision‑making.
This session will explore:
- How advances in LC‑MS/MS, HRMS, and multi‑omics are redefining PFAS biomonitoring
- Which PFAS compounds, metabolites, and exposure biomarkers should be prioritized for meaningful assessment
- How measurement challenges (e.g. ultra‑trace detection, matrix effects, isomer resolution) directly influence toxicological models and global risk assessment
- Emerging analytical strategies supporting evidence‑based legislation and population‑level health protection
Who should attend?
- Analytical chemists developing LC‑MS/MS or HRMS workflows for PFAS exposure and metabolomics
- Toxicologists and clinical researchers integrating analytical data into metabolic and health‑outcome models
- Regulatory and EHS (environmental, health, and safety) professionals evaluating PFAS risk in fast-moving consumer goods, cosmetics, and personal care
- Public health policy makers seeking clarity on which biomarkers and analytical endpoints drive next‑gen legislation
Webinar details
- Cost: Free to attend
- Location: Online
- Duration: 60 minutes
Certificate of attendance
- If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
- If you view the on-demand webinar, you can request a certificate of attendance by emailing [email protected].
Speaker: Dr. Anna Lindell (Co-Founder & VP Technology, Cambiotics, Researcher, University of Cambridge)
Dr. Anna Lindell specializes in the development of biotechnological solutions for environmental remediation. Her research at the University of Cambridge focuses on the molecular mechanisms of contaminant degradation, specifically how biological systems can be leveraged to break down persistent substances.
As Co-Founder and VP of Technology at Cambiotics, she translates these laboratory findings into scalable technologies designed to address the challenges of PFAS contamination in the field.
Speaker: Dr. Mohamed Abdallah (Chair in Environmental Chemistry, University of Birmingham)
Dr Mohamed Abdallah has extensive experience in applying mass spectrometric techniques for analysis of trace levels of environmental pollutants in biotic and abiotic matrices including different human tissues. He has particular interest in assessing the risk from human exposure to emerging contaminants using various exposure and pharmacokinetic models. Abdallah is also actively engaged in microplastics research.
Dr Mohamed Abdallah is part of the Birmingham Plastics Network, an interdisciplinary team of more than 40 academics working together to shape the fate and sustainable future of plastics.
Speaker: Dr. Luigi Margiotta-Casaluci (Senior Lecturer in Toxicology, King's College London)
Dr. Luigi Margiotta-Casaluci focuses on the biological impact of environmental stressors through the lens of predictive toxicology. Based at King’s College London, his work utilizes New Approach Methodologies (NAMs) and advanced modeling to evaluate how chemical mixtures interact with human and ecosystem health. By integrating pharmacological principles with toxicological data, he works to define the physiological risks associated with PFAS exposure and inform clinical and regulatory understanding.
Moderator: Lucy Lawrence (Science Editor, SelectScience)
Lucy Lawrence is an NHS-trained haematological biomedical scientist by background, a foundation that informs her work in making complex scientific research accessible to a global audience. As Science Editor at SelectScience, she co-leads the "Accelerating Science in PFAS" initiative, an editorial program examining the full lifecycle of forever chemicals over 2026, from ultra-trace detection and method validation to regulatory compliance and remediation.
